According to the Perinatal Guidelines: "Clinicians are encouraged to submit to the Antiretroviral Pregnancy Registry data for all patients who conceive while receiving ARV drugs or who receive ARV drugs during pregnancy."*

The Antiretroviral Pregnancy Registry enrolls patients through their Health Care Providers. For information on the Registry and related information follow the “Health Care Providers” link below.

If you are interested in learning about the Registry or other related information or sites, follow the "Patients" link below:

The success of the Registry depends on the continued participation of Health Care Providers who register patients and assist in providing follow-up information postpartum. The support and participation of providers who enroll and continue to enroll patients are greatly appreciated.

* Panel on Treatment of HIV During Pregnancy and Prevention of Perinatal Transmission. Recommendations for the Use of Antiretroviral Drugs During Pregnancy and Interventions to Reduce Perinatal HIV Transmission in the United States. Department of Health and Human Services. Available at (https://clinicalinfo.hiv.gov/sites/default/files/guidelines/documents/perinatal-hiv/guidelines-perinatal.pdf). Accessed 06May2024[Page C-36].